Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (1481-1490 of 1,779) with videos related to

Pageof 178
Sort By:
Mabs|May 26, 2017
Engineering humanized antibody framework sequences for optimal site-specific conjugation of cytotoxinsJared L Spidel, Earl F Albone, Xin Cheng, et al.
Mabs|September 7, 2016
Utility of immunodeficient mouse models for characterizing the preclinical pharmacokinetics of immunogenic antibody therapeuticsMaria Myzithras, Tammy Bigwarfe, Hua Li, et al.
Mabs|September 7, 2016
Simultaneous monitoring of oxidation, deamidation, isomerization, and glycosylation of monoclonal antibodies by liquid chromatography-mass spectrometry method with ultrafast tryptic digestionYi Wang, Xiaojuan Li, Yan-Hui Liu, et al.
Mabs|September 6, 2016
Methylated α-tubulin antibodies recognize a new microtubule modification on mitotic microtubulesIn Young Park, Pratim Chowdhury, Durga Nand Tripathi, et al.
Mabs|September 10, 2016
Molecular basis for the mechanism of action of an anti-TACE antibodyLi Peng, Kimberly Cook, Linda Xu, et al.
Mabs|September 10, 2016
Target-independent variable region mediated effects on antibody clearance can be FcRn independentRyan L Kelly, Yao Yu, Tingwan Sun, et al.
Mabs|June 30, 2018
Heterologous recombinant expression of non-originator NISTmAbLila Kashi, Katharina Yandrofski, Renae J Preston, et al.
Mabs|May 3, 2017
Affinity of human IgG subclasses to mouse Fc gamma receptorsGillian Dekkers, Arthur E H Bentlage, Tamara C Stegmann, et al.
Mabs|January 16, 2010
Bispecific antibodies for cancer therapy: the light at the end of the tunnel?Patrick Chames, Daniel Baty
Mabs|January 16, 2010
Generation and characterization of chicken monoclonal antibodies against human LOX-1Shin Iwamoto, Norihisa Nishimichi, Yoshiko Tateishi, et al.
Pageof 178

Showing results (1481-1490 of 1,779) with videos related to

Sort By:
Pageof 178
Mabs|May 26, 2017
Engineering humanized antibody framework sequences for optimal site-specific conjugation of cytotoxinsJared L Spidel, Earl F Albone, Xin Cheng, et al.
Mabs|September 7, 2016
Utility of immunodeficient mouse models for characterizing the preclinical pharmacokinetics of immunogenic antibody therapeuticsMaria Myzithras, Tammy Bigwarfe, Hua Li, et al.
Mabs|September 7, 2016
Simultaneous monitoring of oxidation, deamidation, isomerization, and glycosylation of monoclonal antibodies by liquid chromatography-mass spectrometry method with ultrafast tryptic digestionYi Wang, Xiaojuan Li, Yan-Hui Liu, et al.
Mabs|September 6, 2016
Methylated α-tubulin antibodies recognize a new microtubule modification on mitotic microtubulesIn Young Park, Pratim Chowdhury, Durga Nand Tripathi, et al.
Mabs|September 10, 2016
Molecular basis for the mechanism of action of an anti-TACE antibodyLi Peng, Kimberly Cook, Linda Xu, et al.
Mabs|September 10, 2016
Target-independent variable region mediated effects on antibody clearance can be FcRn independentRyan L Kelly, Yao Yu, Tingwan Sun, et al.
Mabs|June 30, 2018
Heterologous recombinant expression of non-originator NISTmAbLila Kashi, Katharina Yandrofski, Renae J Preston, et al.
Mabs|May 3, 2017
Affinity of human IgG subclasses to mouse Fc gamma receptorsGillian Dekkers, Arthur E H Bentlage, Tamara C Stegmann, et al.
Mabs|January 16, 2010
Bispecific antibodies for cancer therapy: the light at the end of the tunnel?Patrick Chames, Daniel Baty
Mabs|January 16, 2010
Generation and characterization of chicken monoclonal antibodies against human LOX-1Shin Iwamoto, Norihisa Nishimichi, Yoshiko Tateishi, et al.
Pageof 178